September 26, 2012 (Ottawa, Ontario) — Primary-care practitioners may be putting the lives of patients with prosthetic heart valves at risk by switching their anticoagulation from warfarin to newer ...
Approximately 1 in 10 transcatheter aortic valve replacement (TAVR) procedures in the U.S. were for an off-label indication, with similar 1-year mortality rates compared to on-label use, suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results